Currently, there is a growing interest in the use of probiotic products, and there are many of them in the market. With the growing interest, greater emphasis is placed on the identification of declared probiotic microorganisms. Precise identification of microbial composition is often a difficult task and it requires more advanced methods especially in the field of molecular diagnostics. The diploma thesis was focused on the verification of the presence od declared probiotic microorganisms in probiotic food supplements GS Laktobacily Forte 21, Biopron 9 Premium and Linex® Forte. DNA was isolated from the complex matrices by phenol extraction, commercial kit and magnetic carriers F79/L3-PLL in the quality suitable for PCR. Subsequently, the isolated DNA was amplified by real-time polymerase chain reaction using genus- and species-specific primers. The specific PCR product was subjected to agarose gel electrophoresis, whereas species identification was not always in compliance with the data declared by producers. The next part of the thesis was focused on polymerase chain reaction with high-resolution melting analysis to distinguish bacterial strains belonging to the Lactobacillus group and to identify probiotic microorganisms present in the complex matrices of the probiotic food supplements. Eight primer sets were tested (V1F HRM a V1R-HRM, CHAU-V3F a CHAU-V3R, CHAU-V6F a CHAU-V6R, LAC2 a LAC4, LAC1 a LAC2, P1V1 a P2V1, poxcDNAFw a poxPromRVC, poxcDNAFw a poxPromRVT). Three primer pairs (V1F HRM a V1R-HRM, poxcDNAFw a poxPromRVC, poxcDNAFw a poxPromRVT) were evaluated as the most suitable for distinguishing Lactobacillus bacterial strains.

The aim of present work is cultivation of probiotic bacteria L. acidophilus, B. breve and B. longum in such a way that the culture forms cells clusters or comprehensive biofilm on the variety of free carriers. Biofilm formation of L. acidophilus on the silica from point of view bile and acid tolerance in gastrointestinal tract was studied. While the number of living cells in planktonic form (planktonic form) at pH 1 fell by 30 %, the viability of the biofilm cells was maintained to 90 % under the same environmental conditions. The biofilm culture showed also the protection against environment contained bile. Furthermore, the possibilities of drying procedures of biofilm cultures used as commercial technologies in pharmaceutical industry were studied. The comparison of freeze-drying and fluidization bed drying showed, that freeze-drying is more suitable method, which is able to achieve higher amount of viable cells after drying than fluidization bed drying. The effectivity of freeze-drying method is dependent on the selection of suitable cryprotective medium. In this case, about 90 % higher viability after freeze drying was achieved in comparison with fluidization bed drying. Finally, the industrial processing of probiotic strains into the solid dosage form was studied. Tablets should be produced at hardness between 70 and 90 N and water activity of tablet mixture can be maintained below 0.3. Consequently, the drying step of the tablets in a hermetically closed space with at least 10 % of silica gel must be ensured. Thereafter, the tablets contain (5.4 ± 0.7)109 viable cells after 6 months of drying process. Capsule production technology has no significant effect on the cell‘s viability during production. The triplex blistering foil for primary blistering of probiotic capsules was chosen. The triplex foil, which has low values of water vapour transition rate (0.07 g H2O / (m2 × day) and oxygen transition rate (0.01 cm3/m2 × day), was chosen. Other studied blistering foils commonly used in the pharmaceutical industry are not suitable for long storage of solid dosage forms contained probiotics.

Although strong protective immune response is essential for preventing invasion by pathogens, equivalent responses against antigens originating from commensal bacteria can lead to chronic inflammatory diseases, such as inflammatory bowel disease (IBD). Manipulating the mucosal immune responses with microbial antigens might be an excellent tool to IBD therapy or prevention. Our aim was to gain some insight into the regulation of the intestinal inflammation and to isolate bacterial immunomodulatory components that could be used in intestinal inflammation therapy and prevention. One particular mechanism of how healthy colon tissue regulates the inflammation during acute experimental colitis is through modulation of bioavailability of glucocorticoids (GCs) in gut mucosa. Here, we show that intestinal inflammation changes the local GC metabolism, which ultimately leads to decrease in inflammatory readiness of cells in the gut mucosa and in mesenteric lymph nodes. This pre-receptor regulation of GC function could represent an important homeostatic function of the gut mucosa. The actual triggers of intestinal inflammation in IBD seem to be either microbial dysbiosis or microbes with special "pathogenic" abilities, which both could be rectified by feeding with probiotics. Here, we report that oral feeding with live...

Although strong protective immune response is essential for preventing invasion by pathogens, equivalent responses against antigens originating from commensal bacteria can lead to chronic inflammatory diseases, such as inflammatory bowel disease (IBD). Manipulating the mucosal immune responses with microbial antigens might be an excellent tool to IBD therapy or prevention. Our aim was to gain some insight into the regulation of the intestinal inflammation and to isolate bacterial immunomodulatory components that could be used in intestinal inflammation therapy and prevention. One particular mechanism of how healthy colon tissue regulates the inflammation during acute experimental colitis is through modulation of bioavailability of glucocorticoids (GCs) in gut mucosa. Here, we show that intestinal inflammation changes the local GC metabolism, which ultimately leads to decrease in inflammatory readiness of cells in the gut mucosa and in mesenteric lymph nodes. This pre-receptor regulation of GC function could represent an important homeostatic function of the gut mucosa. The actual triggers of intestinal inflammation in IBD seem to be either microbial dysbiosis or microbes with special "pathogenic" abilities, which both could be rectified by feeding with probiotics. Here, we report that oral feeding with live...

In der vorliegenden Arbeit wurde in einem in vitro-Modell mit porcinen intestinalen Epithelzellen (IPEC-J2) der Einfluss des probiotischen E. coli Nissle 1917 (EcN) auf die Infektion mit atypischen EPEC (aEPEC) untersucht. EcN reduzierte bei Vorinkubation auf IPEC-J2 die aEPEC-Infektion drastisch. Konfokale Laserscanning- und Elektronenmikroskopie zeigten, dass EcN die Adhäsion und Mikrokoloniebildung inhibierte, jedoch nicht die Ausbildung von Attaching and Effacing-Läsionen adhärenter aEPEC. Der inhibierende Effekt von EcN wurde durch dessen sehr gute Adhäsionsfähigkeit an IPEC-J2 vermittelt. Die F1C-Fimbrien wurden als wichtigster Adhäsionsfaktor von EcN identifiziert. Darüber hinaus waren auch H1-Flagellen durch Ausbildung interbakterieller Verbindungen maßgeblich an der Adhäsion des Stammes beteiligt. In gleichem Maß wie die Vorinkubation von EcN reduzierte die Koinkubation seines Kulturüberstandes die aEPEC-Infektion, was auf die Abgabe eines inhibierenden Faktors in den Kulturüberstand schließen lässt. Dieser Faktor wurde auch von anderen pathogenen sowie nicht pathogenen E. coli-Stämmen in Schüttelkultur gebildet und scheint deshalb nicht spezifisch für EcN zu sein. Jedoch ermöglichte erst die gute Adhäsionsfähigkeit von EcN auf der Epithelzelloberfläche die Abgabe ausreichender Mengen des Inhibitors und eine Beeinflussung der aEPEC-Infektion. Die Ergebnisse weisen darauf hin, dass durch EcN die initiale Anheftung von aEPEC an die Wirtszelle unterbunden wird. Der inhibierende Effekt von EcN auf die aEPEC-Infektion war zeitabhängig. Im Gegensatz zur Vorinkubation erhöhten Ko- und Nachinkubation von EcN die Adhäsion von aEPEC und hatten einen geringeren inhibierenden Effekt auf die Mikrokoloniebildung. Dieser gegensätzliche Effekt auf die Adhäsion von aEPEC wird möglicherweise von einem zweiten Faktor hervorgerufen. Dieser scheint nur dann wirksam zu sein, wenn der inhibierende Faktor in zu geringer Konzentration oder erst nach Adhäsion von aEPEC vorliegt. / In this study, the effects of the probiotic E. coli strain Nissle 1917 (EcN) on host cell infection with atypical enteropathogenic E. coli (aEPEC) were investigated in an in vitro porcine intestinal epithelial cell model (IPEC-J2). In pre-incubation experiments, EcN drastically reduced the infection efficiencies of aEPEC. Using confocal laser scanning microscopy and scanning electron microscopy, it was shown that EcN inhibited the attachment and formation of microcolonies, but not the formation of attaching and effacing lesions by adherent aEPEC. The inhibitory effect was mediated by the adherent properties of EcN to epithelial cells. The F1C fimbriae were identified as the most important adhesion factor of EcN in vitro. Furthermore, the H1 flagellae were also shown to be involved in the adhesion of EcN, serving as bridges between bacterial cells. Co-incubation of culture supernatants of EcN reduced the infection efficiencies of aEPEC to the same extent as in pre-incubation with EcN bacteria, indicating the secretion of an inhibitory factor by EcN. This factor was also secreted by other pathogenic and non-pathogenic E. coli strains in shaking culture and therefore does not appear to be specific for EcN. However, the outstanding ability of EcN to adhere to epithelial cells largely contributes to the secretion of sufficient concentrations of this inhibitory factor und to the influence on the aEPEC infection. The results suggest that EcN interferes with the initial adhesion of aEPEC to host cells. The inhibitory effect of EcN was found to be time-dependent. In contrast to pre-incubation experiments, co- and post-incubation of EcN actually increased the adhesion efficiencies of aEPEC and showed only minor effects on microcolony formation. This second effect of EcN on aEPEC adhesion, possibly due to a second factor, appears only to be effective when the putative inhibitory factor is either present at low concentrations or after aEPEC is already adherent to host cells.

The work was comprehensively focused on the development of adhesive forms of probiotics in the form of a biofilm on combined carriers with a prebiotic component. The second part dealed with the influence of food on the multiplication and survival of selected types of probiotic bacteria. Subsequently, the effect of individualized probiotic supplements on changes in the human intestinal microbiome was monitored. Suitable adherent probiotic strains for biofilm formation were selected and tested. Methods have been introduced and different variants of carriers for culturing and binding bacteria have been tested. In vitro experiments verified the stability of biofilm stucture and its resistance to low pH, bile and antibiotics in comparison with the planktonic cell form. The antimicrobial effect of probiotic strains in the form of a biofilm was studied. The cultivation of the multispecies biofilm on the combined carrier was optimized and the stability of the biofilm and the final viability of probiotic bacteria were confirmed. Furthermore, the influence of various foods and beverages on the viability of probiotic bacteria was evaluated with emphasis on the simulation of passage through the gastrointestinal tract. Both models, solutions with standardised concentrations of alcohol, sugar, salts, proteins or different pH and different types of real foods and beverages were tested. The effect of food and beverages was tested on monocultures of Lactobacillus acidophilus, Bifidobacterium breve and on probiotic capsules containing a mixed culture of probiotic microorganisms. The survival of probiotics in various food matrices in the simulated gastrointestinal tract was quantitatively different. We managed to define foods suitable for supporting the multiplication of probiotic bacteria. A separate part of the work was focused on the targeted modulation of the intestinal microbiome by individualized probiotics that were prepared on the basis of molecular biological analyzes of the intestinal microbiome aimed at detecting the percentage of lactobacilli, bifidobacteria and phylum Firmicutes and Bacteroidetes. Personalized probiotic supplementation confirmed the positive effect of this approach on microbiome changes, especially on the increase of the content of lactobacilli, bifidobacteria and the overall diversity of the microbiome.

The presented doctoral thesis is focused on preparation, characterization and application of organic micro- and nanoparticles as transport systems for active components and some their complex natural sources. Active component were packed into liposomes and polysaccharide particles. As active components were used caffeine, some drugs – clotrimazole and ibuprofen, further antioxidants and vitamins. Antimicrobial herbs and spices extract, antimicrobial peptides lysozyme, nisin and other antimicrobial ingredients were encapsulated too. Encapsulation of selected hydrolytic enzymes was tested, too. Particles were also used for encapsulation of probiotic strains Bifidobacterium breve and Lactobacillus acidophilus and prebiotic components. These prebiotics were co-encapsulated into capsules with probiotic cells. Natural extracts were encapsulated e.g. extracts of guarana, ginseng, goji, green barley, propolis, black, green and white tea, coffee, fruit and vegetable extracts. The efficiency of encapsulation was determined by HPLC/PDA and by spectrophotometry. Long-term stability of particles and amount of released component in model/real foods, in model cosmetic conditions and in a model physiological environment were monitored too. Size of prepared liposomes and polysaccharide particles was determined by dynamic light scattering and by light microscopy and electron microscopy, respectively. Stability of the particles was measured using a zeta potential. Also, analytical centrifugation was used to measurement of sedimentation velocity and stability of the prepared particles. The antimicrobial activity were tested using two Gram-positive (Bacillus subtilis, Micrococcus luteus), two Gram-negative (Escherichia coli, Serratia marcescens) bacteria and one fungal strains (Candida glabrata). For determining the antimicrobial properties of active component and prepared particles two the most widely used methods were used - agar diffusion method and broth dilution method. The viability of probiotic strains were performed using flow cytometry and fluorescence microscopy. Encapsulation of active component was successful in all types of particles. Liposome showed a very good long-term stability mainly in water conditions with neutral pH and polysaccharide particles were stable in acidic conditions. Prepared particles showed a very good stability in model stomach environment, while in model intestines environments particles were disintegrated and active component were released. Prepared particles with encapsulated caffeine as well as other tested antioxidants and vitamins could be used to modern types of energy drinks, food supplements and also for some cosmetics applications. Encapsulated antimicrobial components could be used for food application as well as for cosmetics and pharmaceutical application like antimicrobial wound formulation. Encapsulated enzymes can be used for controlled release of proteases in wound healing, as delivery systems in digestive tract and as a part of pharmaceutical preparative and food supplements for enzyme therapy. The study revealed that encapsulation of probiotics and also co-encapsulation of probiotics with prebiotics exhibited longer stability of particles and survival bacterial cells. So, prepared particles are suitable for use to food product with beneficial effects on the human body.

The use of probiotics has emerged in the last decades as a promising strategy when it comes to the treatment of inflammatory diseases. Through modulation of composition of the intestinal microbiota and the signalling it provides, probiotics can favourably tune the immune system. Beneficial effects of probiotic treatment have been documented in multiple animal inflammatory disease models. The effect of probiotic treatment on uveitis-a sight- threatening disease-has however not yet been described. In our study, we have tested two commercially available probiotics-Escherichia coli Nissle 1917 (EcN) and Escherichia coli O83:K24:H31 (EcO)-in the treatment of experimental autoimmune uveitis (EAU). The disease severity was assessed by ophthalmoscopy and histology, proportions of leukocyte populations and intracellular expression of cytokines were evaluated by flow cytometry and the gut immune environment was analysed by tissue culture and ELISA. We found that prophylactic and early oral treatment with EcN reduces the severity of EAU. However, EcO treatment does not. The effects were accompanied by immune changes including a lowered production of inflammatory cytokines in Peyer's patches, a shift in macrophage populations in ileum and mesenteric lymph nodes or a reduced IRBP-specific response of CD4+ T...

In der vorliegenden Arbeit wurde der Einfluss von Prä- und Probiotika auf bakterielle Translokation (BT) und postoperative Infektionen nach großen viszeralchirurgischen Eingriffen untersucht. Dabei wurde aus methodischen Gründen zunächst BT nach Leber- (LR) und Colonresektion (CR) allein oder in Kombination experimentell im Rattenmodell quantifiziert und deren potentielle Pathomechanismen untersucht. Anschließend wurde der Einfluss von einzelnen Probiotika und einer Kombination verschiedener Probiotika und Präbiotika auf die Inzidenz bakterieller Infektionen nach Lebertransplantation (LTX) und pyloruserhaltender Pankreaskopfresektion (PPPD) in zwei prospektiv randomisierten klinischen Studien analysiert. Im experimentellen Teil der Untersuchungen wurde BT nach LR vor allem in Leber und Milz, nach CR hauptsächlich in mesenterialen Lymphknoten (MLK) und Milz nachgewiesen. Kombination von LR und CR führte zu einer Potenzierung der BT, parallel zum Ausmaß der LR. Durch Gabe von Probiotika wurde die Konzentration von Bakterien in den MLK signifikant gesenkt. Tiere mit einer hohen coecalen Laktobazillenkonzentration hatten eine signifikant niedrigere bakterielle Konzentration in allen untersuchten Organen als Tiere mit weniger Laktobazillen. CR führten zu einer Zunahme der coecalen gramnegativen Bakterienkonzentration und zu einer Abnahme der Laktobazillen. Histologische Veränderungen der Darmmukosa wurden nicht beobachtet. Die parazelluläre Permeabilität für Ionen, nicht aber für die höhermolekulare Laktulose war im Colon in allen Gruppen im Vergleich zur Kontrollgruppe erhöht. Probiotika beeinflussten die Zusammensetzung der coecalen Flora und damit auch die BT. In der ersten klinischen Studie verminderte postoperative orale Gabe von Laktobazillus plantarum und einer ballaststoffhaltigen Ernährungslösung die Inzidenz von bakteriellen Infektionen nach LTX im Vergleich zu selektiver Darmdekontamination und ballaststofffreier Ernährung signifikant. Die Gabe von Ballaststoffen und hitzeinaktivierten Laktobazillen führte zwar auch zu einer geringen Reduktion der Infektionen; diese war jedoch nicht signifikant. In der Mehrzahl wurden enteropathogene Bakterien isoliert. Die zweite klinische Studie untersuchte den Einfluss einer Kombination von vier verschiedenen Milchsäurebakterien und vier Präbiotika auf die Inzidenz bakterieller Infektionen nach LTX und PPPD. Im Vergleich zu Präbiotika und Placebo kam es zu einer deutlichen Verminderung der Infekte, die nach LTX auch signifikant war. In beiden Studien wurde die enterale Ernährung gut vertragen mit relativ wenig Nebenwirkungen. BT tritt somit sehr häufig auch nach kleineren viszeralchirurgischen Eingriffen auf und hat organspezifisch verschiedene Ursachen. Probiotika konnten sowohl tierexperimentell die BT vermindern als auch klinisch die Inzidenz bakterieller Infektionen nach großen viszeralchirurgischen Eingriffen senken. Da sie leicht zu verabreichen sind und wenig Nebenwirkungen verursachen, könnten sie breit eingesetzt werden. / In the present study, the impact of pre- and probiotics on bacterial translocation (BT) and postoperative bacterial infection rates was assessed. Due to methodological reasons, we first quantified BT following single liver (LR) and colon resection (CR) or a combination of both and analysed potential pathogenic mechanisms for BT. Then, we performed two prospective randomised clinical studies to analyse the influence of a single probiotic strain and a combination of different pre- and probiotics on the incidence of bacterial infections in patients with liver transplantation (OLT) or pylorus preserving partial pancreatoduodenectomy (PPPD). In the rat model, BT after LR mainly occurred in the liver and spleen, after CR mainly in the mesenteric lymph nodes (MLN) and spleen. BT was increased in the animals with combined operation, in parallel to the extent of liver resection. Probiotics significantly decreased the bacterial concentration in the MLN. Animals with a high cecal concentration of lactobacilli had significantly less BT than the others. CR led to an increase of cecal gramnegative bacterial concentrations and to a decrease of lactobacilli. No histological changes were observed in the intestine. Paracellular permeability for ions, but not for the larger molecule lactulose, was increased in the colon in all groups compared to the sham group. Probiotics had an influence on cecal bacterial concentration. In the first clinical study, postoperative oral administration of Lactobacillus plantarum and a fibre-enriched enteral diet significantly decreased bacterial infection rates after OLT compared to selective bowel decontamination and a fibre-free diet. Fibre and heat-inactivated Lactobacillus also led to a slight, but not significant decrease of infections. Mainly gut-derived bacteria were isolated. The second clinical study analysed the influence of a combination of four different lactic acid bacteria and fibres on bacterial infection rates after OLT and PPPD. Compared to fibres and placebo, infection rates were significantly lower after OLT and markedly lower after PPPD. In both studies, the study substances were well tolerated without serious side effects. BT even occurs following minor abdominal surgery and is caused by different mechanisms related to the kind of operation. Probiotics were able to diminish BT in the rat model as well as to decrease bacterial infection rates following major abdominal surgery in the clinical studies. As they are easy to administer and do not cause severe side effects, they could be useful in clinical practice.

Einleitung: Das Probiotikum E. coli Nissle 1917 (EcN) wird seit einigen Jahren erfolgreich in der Behandlung chronisch entzündlicher Darmerkrankungen angewendet, der zugrunde liegende Wirkmechanismus ist jedoch nur unzureichend geklärt. T-Zellen spielen in der intestinalen Immunhomöostase und der Pathogenese von CED eine zentrale Rolle. Ziel: Den Einfluss von EcN auf humane T-Zellen weitergehend zu charakterisieren. Methoden: CD3-stimulierte periphere und Lamina propria T-Zellen wurden mit verschiedenen Konzentrationen eines E. coli Nissle 1917 konditionierten Mediums (EcN-CM) oder aber hitzeinaktivierten E. coli Nissle 1917 (hi-EcN) kultiviert. Die Expression von zellzyklus- und apoptoseassoziierten Regulationsproteinen sowie DNA-Gehalt, Zellzykluskinetik, Apoptoserate und Zellexpansion wurden durchflusszytometrisch und im Western Blot bestimmt. Die Sekretion von Cytokinen wurde mit dem Cytometric Bead Assay bestimmt. Ergebnisse: EcN-CM, nicht aber hitzeinaktivierte E. coli Nissle 1917 hemmt die Zellzyklusprogression und die Expansion von stimulierten, humanen peripheren T-Zellen. Ursächlich hierfür ist eine verminderte Expression der Cykline A, B1, D2 und E mit einer konsekutiv verminderten Phosphorylierung des Retinoblastomaproteins. Periphere T-Zellen sezernieren unter EcN-CM vermindert IL-2, IFN-gamma und TNF-alpha, während die Sekretion des antiinflammatorischen IL-10 durch EcN-CM heraufreguliert wird. Im Gegensatz zur potenten Beeinflussung des Zellzyklus, wurde die Apoptose von PBT durch E. coli Nissle 1917 nicht moduliert. Während periphere T-Zellen durch EcN-CM in ihrer Zellzyklusprogression und Expansion gehemmt wurden, zeigte sich kein derartiger Effekt auf ortständige Lamina propria T-Lymphozyten. Diskussion: Bei chronisch entzündlichen Darmerkrankungen kommt es zu einer Rekrutierung und Aktivierung von peripheren T-Zellen in die intestinale Mukosa. Durch die differenzielle Beeinflussung des Immunsystems, bei der aktivierte periphere T-Zellen inhibiert, die ortsständigen T-Zellen jedoch in ihrer Funktion nicht gestört werden, könnte E. coli Nissle 1917 dazu beitragen, die mukosale Entzündungsreaktion zu limitieren, während die intestinale Immunhomöostase gewahrt bleibt. Als wirksames Agens kommen kleine, hitzestabile bakterielle Produkte wie Lipopolysaccharide, bakterielle Lipoproteine, CPG-DNA, Lipoteichonsäuren und Peptidoglykane in Frage. Die Ergebnisse der vorliegenden Arbeit liefern weitere Hinweise, dass Probiotika einen breiten Einfluss auf das humane Immunsystem haben und decken zugrundeliegende Mechanismen auf. / Introduction: Although probiotic Escherichia coli strain Nissle 1917 (EcN) has been proven to be efficacious for the treatment of inflammatory bowel diseases, the underlying mechanisms of action still remain elusive. T cells play a major role in the pathogenesis of inflammatory bowel disease. Aims: To analyze the effects of E. coli Nissle 1917 on cell cycling and apoptosis of peripheral blood and lamina propria T cells. Methods: Anti-CD3-stimulated peripheral or lamina propria T cells were treated with E. coli Nissle 1917-conditioned medium (EcN-CM) or heat-inactivated E. coli Nissle 1917. Expression of cell cycle or apoptosis related proteins was determined by immunoblotting, DNA content, cell cycle kinetics, cell expansion and apoptosis were measured by flow cytometry. Cytokine levels in culture supernatants were assessed by cytometrc bead array. Results: EcN-CM but not heat-inactivated EcN inhibits cell cycling and expansion of peripheral T cells. EcN-CM decreases expression of Cyclin A, B1, D2 and E and thus reduces phosphorylation of retinoblastomaprotein in CD3-stimulated peripheral T cells. Further, secretion of proinflammatory cytokines IL-2, IFN-gamma and TNF-alpha is reduced while antiinflammatory IL-10 is increased under treatment with EcN-CM. In contrast to peripheral T cells, expansion and cell cycle progression of lamina propria T cells was not affected by EcN-CM. Apoptosis of was not modulated by EcN-CM. Discussion: The differential reaction of circulating and tissue-bound T cells towards E. coli Nissle 1917 may explain the beneficial effect of EcN in intestinal inflammation. EcN may downregulate the expansion of newly recruited T cells into the mucosa and thus limit intestinal inflammation, while already activated tissue-bound T cells may eliminate deleterious antigens in order to maintain immunological homeostasis. Possible agents, for which immunomodulatory effects are known, include heat-stable bacterial products like lipopolysaccharids, bacterial lipoproteins or bacterial DNA-motifs.